Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
18,641,131
-
Shares change
-
+1,003,729
-
Total reported value, excl. options
-
$370,954,367
-
Value change
-
+$21,784,116
-
Put/Call ratio
-
140%
-
Number of buys
-
36
-
Number of sells
-
-24
-
Price
-
$19.90
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q3 2016
80 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q3 2016.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,641,131 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,865,647 shares), FMR LLC (3,444,606 shares), JPMORGAN CHASE & CO (2,234,064 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,172,862 shares), BlackRock Fund Advisors (945,216 shares), VANGUARD GROUP INC (875,053 shares), First Eagle Investment Management, LLC (854,055 shares), FRANKLIN RESOURCES INC (686,500 shares), MORGAN STANLEY (441,501 shares), and BlackRock Institutional Trust Company, N.A. (396,384 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.